Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 484731, 10 pages
http://dx.doi.org/10.1155/2014/484731
Research Article

Glutaric Acid-Mediated Apoptosis in Primary Striatal Neurons

1Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
2Department of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
3Laboratory of Infectious Immunology, Department of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

Received 12 February 2014; Revised 20 April 2014; Accepted 21 April 2014; Published 12 May 2014

Academic Editor: Janet K. Kern

Copyright © 2014 Fengyan Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kölker, S. F. Garbade, C. R. Greenberg et al., “Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency,” Pediatric Research, vol. 59, no. 6, pp. 840–847, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. B. R. Funk, A. N. Prasad, P. Frosk et al., “Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort,” Brain, vol. 128, no. 4, pp. 711–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Christensen, A. Ribes, B. Merinero, and J. Zschocke, “Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency,” Journal of Inherited Metabolic Disease, vol. 27, no. 6, pp. 861–868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Jafari, O. Braissant, L. Bonafé, and D. Ballhausen, “The unsolved puzzle of neuropathogenesis in glutaric aciduria type I,” Molecular Genetics and Metabolism, vol. 104, no. 4, pp. 425–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. V. Magni, M. S. Oliveira, A. F. Furian et al., “Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats,” Brain Research, vol. 1185, no. 1, pp. 336–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Latini, G. C. Ferreira, K. Scussiato et al., “Induction of oxidative stress by chronic and acute glutaric acid administration to rats,” Cellular and Molecular Neurobiology, vol. 27, no. 4, pp. 423–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. W. Sauer, J. G. Okun, G. Fricker et al., “Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency,” Journal of Neurochemistry, vol. 97, no. 3, pp. 899–910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. N. Busanello, L. Pettenuzzo, P. H. Botton et al., “Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice,” Life Sciences, vol. 92, no. 2, pp. 137–142, 2013. View at Google Scholar
  9. D. M. Koeller, M. Woontner, L. S. Crnic et al., “Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type 1,” Human Molecular Genetics, vol. 11, no. 4, pp. 347–357, 2002. View at Google Scholar · View at Scopus
  10. W. J. Zinnanti, J. Lazovic, C. Housman et al., “Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I,” Journal of Clinical Investigation, vol. 117, no. 11, pp. 3258–3270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. U. Amaral, “Marked reduction of Na+, K+-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice,” Molecular Genetics and Metabolism, vol. 107, no. 1-2, pp. 81–86, 2012. View at Google Scholar
  12. J. Lamp, B. Keyser, D. M. Koeller, K. Ullrich, T. Braulke, and C. Mühlhausen, “Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells,” Journal of Biological Chemistry, vol. 286, no. 20, pp. 17777–17784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Gerstner, A. Gratopp, M. Marcinkowski, M. Sifringer, M. Obladen, and C. Bührer, “Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency,” Pediatric Research, vol. 57, no. 6, pp. 771–776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Rosa, C. Schwarzbold, K. B. Dalcin et al., “Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats,” Neurochemistry International, vol. 45, no. 7, pp. 1087–1094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. C. Ferreira, A. Tonin, P. F. Schuck et al., “Evidence for a synergistic action of glutaric and 3-hydroxyglutaric acids disturbing rat brain energy metabolism,” International Journal of Developmental Neuroscience, vol. 25, no. 6, pp. 391–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Jafari, O. Braissant, P. Zavadakova, H. Henry, L. Bonafé, and D. Ballhausen, “Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I,” PLoS ONE, vol. 8, no. 1, Article ID e53735, 2013. View at Google Scholar
  17. S. W. Sauer, S. Opp, A. Mahringer et al., “Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus,” Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1802, no. 6, pp. 552–560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Gao, C. Zhang, X. Fu et al., “Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons,” PLoS ONE, vol. 8, no. 5, Article ID e63084, 2013. View at Google Scholar
  19. B. Seminotti, M. S. da Rosa, C. G. Fernandes et al., “Induction of oxidative stress in brain of glutaryl-CoA dehydrogenase deficient mice by acute lysine administration,” Molecular Genetics and Metabolism, vol. 106, no. 1, pp. 31–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Keyser, M. Glatzel, F. Stellmer et al., “Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1,” Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1782, no. 6, pp. 385–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Thies, C. Meyer-Schwesingerb, J. Lamp et al., “Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1,” Biochimica et Biophysica Acta, vol. 1832, no. 10, pp. 1463–1472, 2013. View at Publisher · View at Google Scholar
  22. W. J. Zinnanti, J. Lazovic, C. Housman et al., “Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I,” Acta Neuropathologica Communications, vol. 2, no. 1, p. 13, 2014. View at Google Scholar
  23. K. B. Bjugstad, W. M. Zawada, S. I. Goodman, and C. R. Freed, “IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures,” Journal of Inherited Metabolic Disease, vol. 24, no. 6, pp. 631–647, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. W. J. Zinnanti, J. Lazovic, E. B. Wolpert et al., “A diet-induced mouse model for glutaric aciduria type I,” Brain, vol. 129, no. 4, pp. 899–910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Marlaire, E. van Schaftingen, and M. Veiga-da-Cunha, “C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA,” Journal of Inherited Metabolic Disease, vol. 37, no. 1, pp. 13–19, 2014. View at Google Scholar
  26. S. W. Sauer, S. Opp, G. F. Hoffmann, D. M. Koeller, J. G. Okun, and S. Kölker, “Therapeutic modulation of cerebral l-lysine metabolism in a mouse model for glutaric aciduria type I,” Brain, vol. 134, no. 1, pp. 157–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Strauss, J. Lazovic, M. Wintermark, and D. H. Morton, “Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency,” Brain, vol. 130, no. 7, pp. 1905–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. A. Strauss, J. Brumbaugh, A. Duffy et al., “Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx,” Molecular Genetics and Metabolism, vol. 104, no. 1-2, pp. 93–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Olivera-Bravo, E. Isasi, A. Fernández et al., “White matter injury induced by perinatal exposure to glutaric Acid,” Neurotoxicity Research, vol. 25, no. 4, pp. 381–391, 2014. View at Google Scholar
  30. M. E. S. Frizzo, C. Schwarzbold, L. O. Porciúncula et al., “3-Hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats,” Neurochemistry International, vol. 44, no. 5, pp. 345–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Olivera-Bravo, A. Fernández, M. N. Sarlabós et al., “Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric Acidemia-I,” PLoS ONE, vol. 6, no. 6, Article ID e20831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. A. Strauss, P. Donnelly, and M. Wintermark, “Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency,” Brain, vol. 133, no. 1, pp. 76–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Galluzzi, I. Vitale, J. M. Abrams et al., “Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012,” Cell Death and Differentiation, vol. 19, no. 1, pp. 107–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Varadkar and R. Surtees, “Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis,” Journal of Inherited Metabolic Disease, vol. 27, no. 6, pp. 835–842, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. M. Lund, E. Christensen, A. S. Kristensen, A. Schousboe, and A. M. Lund, “On the neurotoxicity of glutaric, 3-hydroxyglutaric, and trans-glutaconic acids in glutaric acidemia type 1,” Journal of Neuroscience Research, vol. 77, no. 1, pp. 143–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kölker, G. Köhr, B. Ahlemeyer et al., “Ca2+ and Na+ dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons,” Pediatric Research, vol. 52, no. 2, pp. 199–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. K. B. Dalcin, R. B. Rosa, A. L. Schmidt et al., “Age and brain structural related effects of glutaric and 3-hydroxyglutaric acids on glutamate binding to plasma membranes during rat brain development,” Cellular and Molecular Neurobiology, vol. 27, no. 6, pp. 805–818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Kölker, B. Ahlemeyer, J. Krieglstein, and G. F. Hoffmann, “Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency,” Pediatric Research, vol. 47, no. 4, pp. 495–503, 2000. View at Google Scholar · View at Scopus
  39. V. L. Lagranha, U. Matte, T. G. de Carvalho et al., “Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I,” PLoS ONE, vol. 9, no. 3, Article ID e90477, 2014. View at Google Scholar